Why Is CRISPR Therapeutics Stock Surging Thursday? - CRISPR Therapeutics (NASDAQ:CRSP)

CRISPR Therapeutics AG (NASDAQ:CRSP) shares jumped on Thursday, building on its Feb. 13 earnings report that showed growing momentum for its lead gene therapy and a deepening pipeline.Casgevy Revenue Casgevy, the gene-editing therapy for sickle cell disease and transfusion-dependent beta thalassemia, generated $54 million in the fourth quarter and $116 million for the full-year 2025. A total of 64 patients received infusions in the fourth quarter alone, with 147 initiating treatment through the first cell c ...